Registration Dossier

Data platform availability banner - registered substances factsheets

Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.

The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.

Diss Factsheets

Administrative data

Endpoint:
basic toxicokinetics, other
Type of information:
other: assessment of physchem/ potential metabolic pathway
Adequacy of study:
key study

Data source

Materials and methods

Results and discussion

Applicant's summary and conclusion

Conclusions:
Chemical structure of Zinc diisonoyl dithiocarbamate has main functional group associated with dithiocarbamates, structural functional groups include a Zinc ion with two diisononylamine dithiocarbamate ligands and exists in a divalent and tetravalent form

Relevant physicochemical properties :
)Molecular weight : 745g/mol or Da
Physical form : free flowing powder with mean aerodynamic diameter of 25µm (D50)
Vapour pressure : 8.5 X 10 -4 Pa at 25°C Low vapour pressure
Water solubility : 0.6 mg/l (poorly water soluble)
LogKow : >6.5 Hplc method
Hydrolysis TBD- testing underway
pH 9 ( 10% aq solution- distilled water)
pKa 3.4 ( relaible QSAR)

Absorption
pKa 3.4 – therefore Arbestb Z is largely unionised in stomach and ionised in intestines. We would therefore expect absorption of parent to occur in stomach & minimal parent absorption in intestine
Main routes are inhalation of dust, but dermal absorption is unlikely due to high molecular weight, greater than 500 Da
Absorption is evident with haemtological effects observed in repeat dose studies

Metabolism
Arbestab Z is likely to be metabolised in liver into dialkyldithiocarbamic acid or as a S-glucuronide conjugate with further metabolism to dialkylamine and carbon disulphide as most dithiocarbamates

Distribution
general absorbed dithiocarbamates can be found in following organs, liver, kidneys and thyroid gland, but accumulation of these compounds does not take place because of rapid metabolism.

Elimination
The biotransformation of dithiocarbamates in phase two conjugation with polar/hydrophillic glucuronide results in principle excretion via kidneys.

Executive summary:

Physchemical properties show the test item will undergo rapid metabolism